Thanks to varied new technologies, Alternative and Rapid Microbiological Methods are transforming pharmaceutical microbiology. In this video, sponsored by Celsis, Inc. (http://www.celsis.com), from our Industry Update series, PharmaManufacturing.com's Michele V. Wagner provides an overview of opinions expressed by Pfizer's Claudio Denoya on the impact of, and regulatory landscape surrounding, ARMMs.
Link to this comment:
All Comments (0)